Primary hemostatic capacity of whole blood: A comprehensive analysis of pathogen reduction and refrigeration effects over time

Transfusion

Volumn 53, Issue SUPPL. 1, 2013, Pages

  Pidcoke, Heather F ^a,b,c   McFaul, Steve J ^a,b,c   Ramasubramanian, Anand K ^a,b,c   Parida, Bijaya K ^a,b,c   Mora, Alex G ^a,b,c   Fedyk, Chriselda G ^a,b,c   Valdez Delgado, Krystal K ^a,b,c   Montgomery, Robbie K ^a,b,c   Reddoch, Kristin M ^a,b,c   Rodriguez, Armando C ^a,b,c   Aden, James K ^a,b,c   Jones, John A ^a,b,c   Bryant, Ron S ^a,b,c   Scherer, Michael R ^a,b,c   Reddy, Heather L ^a,b,c   Goodrich, Raymond P ^a,b,c   Cap, Andrew P ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b The University of Texas at San Antonio   (United States)

^c Scientific and Clinical Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT; RIBOFLAVIN;

ADULT; ARTICLE; BLEEDING; BLOOD; BLOOD BANK; BLOOD SAFETY; BLOOD STORAGE; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; CRYOPRESERVATION; DISEASE TRANSMISSION; HEMOSTASIS; HUMAN; INFECTION; METHODOLOGY; RADIATION EXPOSURE; THROMBOCYTE ACTIVATION; THROMBOELASTOGRAPHY; ULTRAVIOLET RADIATION;

ADULT; BLOOD BANKS; BLOOD PRESERVATION; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CRYOPRESERVATION; HEMORRHAGE; HEMOSTASIS; HEMOSTATIC TECHNIQUES; HUMANS; INFECTION; PHOTOSENSITIZING AGENTS; PLATELET ACTIVATION; RIBOFLAVIN; THROMBELASTOGRAPHY; ULTRAVIOLET RAYS;

MLCS; MLOWN;

EID: 84872232512     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12048     Document Type: Article

References (51)

1. Kendrick BG. Blood program in WorldWar II. 1964. [cited 2012 Sep 5]. Available from: URL: http:// history.amedd.army.mil/booksdocs/ wwii/blood/default.htm
2. Neel S, Major General. Medical support of the U.S. Army in Vietnam 1965-1970. 1991. [cited 2012 Sep 5]. Available from: URL: http://history.amedd. army.mil/booksdocs/vietnam/ medicalsupport/default.html
3. Berseus O, Boman K, Nessen SC, Westerberg LA. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion 2013;53(Suppl. 1):114S-23S.
4. Gerhardt RT, Strandenes G, Cap AP, Rentas FJ, Glassberg E, Mott J, Dubick MA, Spinella PC; for the THOR Network and RemTORN Study Group. Remote damage control resuscitation and the Solstrand Conference: defining the need, the language, and a way forward. Transfusion 2013;53(Suppl. 1):9S-16S.
5. Nessen SC, Eastridge BJ, Cronk D, Craig RM, Berséus O, Ellison R, Remick K, Seery J, Shah A, Spinella PC. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets. Transfusion 2013; 53(Suppl. 1):107S-13S.
6. Pidcoke HF, Aden JK, Mora A, Borgman M, Spinella PC, Dubick M, Blackbourne L, Cap AP. 10-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival. J Trauma Acute Care Surg 2012;73(6 Suppl. 5):S445-52.
7. Perkins JG, Cap AP, Spinella PC, Shorr AF, Beekley AC, Grathwohl KW, Rentas FJ, Wade CE, Holcomb JB. Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion 2011;51:242-52.
8. Perkins JG, Cap AP, Spinella PC, Blackbourne LH, Grathwohl KW, Repine TB, Ketchum L, Waterman P, Lee RE, Beekley AC, Sebesta JA, Shorr AF, Wade CE, Holcomb JB. An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma 2009;66(Suppl.):S77- 84; discussion S84-5.
9. Cap AP, Spinella PC, Borgman MA, Blackbourne LH, Perkins JG. Timing and location of blood product transfusion and outcomes in massively transfused combat casualties. J Trauma Acute Care Surg 2012;73(Suppl. 1):S89-94.
10. Spinella PC, Dunne J, Beilman GJ, O'Connell RJ, Borgman MA, Cap AP, Rentas F. Constant challenges and evolution of US military transfusion medicine and blood operations in combat. Transfusion 2012;52:1146-53.
11. Spinella PC, Strandenes G, Rein EB, Seghatchian J, Hervig T. Symposium on fresh whole blood for severe hemorrhagic shock: from in-hospital to far forward resuscitations. Transfus Apher Sci 2012;46:113-7.
12. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009; 66(Suppl.):S69-76.
13. Spinella PC, Reddy HL, Jaffe JS, Cap AP, Goodrich RP. Fresh whole blood use for hemorrhagic shock: preserving benefit while avoiding complications. Anesth Analg 2012; 115:751-8.
14. Rivard GE, Brummel-Ziedins KE,Mann KG, Fan L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005;3:2039-43.
15. Montgomery RK, Reddoch KM, Evani SJ, Cap AP, Ramasubramanian AK. Enhanced shear-induced platelet aggregation due to low temperature storage. Transfusion 2013. doi: 10.1111/j.1537-2995.2012.03917.x.
16. Wenzel F, Hohlfeld T, Giers G. Soluble CD40L release as test for functional platelet loss. Clin Lab 2012;58:337-42.
17. Jobes D, Wolfe Y, O'Neill D, Calder J, Jones L, Sesok-Pizzini D, Zheng XL. Toward a definition of "fresh" whole blood: an in vitro characterization of coagulation properties in refrigerated whole blood for transfusion. Transfusion 2011; 51:43-51.
18. Oswald MW, Hunt HH, Lazarchick J. Normal range of plasma fibrinogen. Am J Med Technol 1983;49:57-9.
19. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63:805-13.
20. Bhangu A, Nepogodiev D, Doughty H, Bowley DM. Metaanalysis of plasma to red blood cell ratios and mortality in massive blood transfusions for trauma. Injury 2012;pii: S0020-1383(12)00296-3.
21. Johansson PI, Oliveri RS, Ostrowski SR. Hemostatic resuscitation with plasma and platelets in trauma. J Emerg Trauma Shock 2012;5:120-5.
22. Dutton RP. Resuscitative strategies to maintain homeostasis during damage control surgery. Br J Surg 2012;99(Suppl. 1):21-8.
23. Kautza BC, Cohen MJ, Cuschieri J, Minei JP, Brackenridge SC, Maier RV, Harbrecht BG, Moore EE, Billiar TR, Peitzman AB, Sperry JL. Changes in massive transfusion over time: an early shift in the right direction? J Trauma Acute Care Surg 2012;72:106-11.
24. Holcomb JB, Zarzabal LA, Michalek JE, Kozar RA, Spinella PC, Perkins JG, Matijevic N, Dong JF, Pati S, Wade CE, Cotton BA, Brasel KJ, Vercruysse GA, MacLeod JB, Dutton RP, Hess JR, Duchesne JC, McSwain NE, Muskat PC, Johannigamn JA, Cryer HM, Tillou A, Cohen MJ, Pittet JF, Marin B, et al. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma 2011;71(Suppl. 3):S318-28.
25. Harm SK, Delaney M, Charapata M, Aubuchon JP, Triulzi DJ, Yazer MH. Routine use of a rapid test to detect bacteria at the time of issue for nonleukoreduced, whole bloodderived platelets. Transfusion 2013. doi: 10.1111/j.1537-2995.2012.03818.x.
26. Engelfriet CP, Reesink HW, Blajchman MA, Muylle L, Kjeldsen-Kragh J, Kekomaki R, Yomtovian R, Hocker P, Stiegler G, Klein HG, Soldan K, Barbara J, Slopecki A, Robinson A, Seyfried H. Bacterial contamination of blood components. Vox Sang 2000;78:59-67.
27. Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability-deleterious effect of refrigerated storage. N Engl J Med 1969;280:1094-8.
28. Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Spinella PC, Shulman I, Nelson J, Demetriades D. Impact of the duration of platelet storage in critically ill trauma patients. J Trauma 2011;71:1766-73; discussion 1773-4.
29. Brasel KJ, Vercruysse G, Spinella PC, Wade CE, Blackbourne LH, Borgman MA, Zarzabal LA, Du F, Perkins JG, Maegele M, Schreiber M, Hess JR, Jastrow KM 3rd, Gonzalez EA, Holcomb JB, Kozar R, MacLeod J, Dutton RP, Duchesne JC, McSwain NE, Muskat P, Johannigamn J, Cryer HM, Pittet JF, Marin B. et al. The association of blood component use ratios with the survival of massively transfused trauma patients with and without severe brain injury. J Trauma 2011;71(Suppl. 3):S343-52.
30. Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, von Andrian UH, Wagner DD, Stossel TP, Hartwig JH. The clearance mechanism of chilled blood platelets. Cell 2003;112:87-97.
31. Hoffmeister KM. The role of lectins and glycans in platelet clearance. J Thromb Haemost 2011;9(Suppl. 1):35-42.
32. Hoffmeister KM, Josefsson EC, Isacc NA, Clausen H, Hartwig JH, Stossel TP. Glycosylation restores survival of chilled blood platelets. Science 2003;301:1531-4.
33. Valeri CR. Circulation and hemostatic effectiveness of platelets stored at 4°C or 22°C: studies in aspirin-treated normal volunteers. Transfusion 1976;16:20-3.
34. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program 2003;575-89.
35. Cancelas JA, Rugg N, Fletcher D, Pratt PG, Worsham DN, Dunn SK, Marschner S, Reddy HL, Goodrich RP. In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood. Transfusion 2011;51:1460-8.
36. Marschner S, Goodrich R. Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother 2011;38:8-18.
37. Goodrich RP, Doane S, Reddy HL. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010;38:20-30.
38. Galan AM, Lozano M, Molina P, Navalon F, Marschner S, Goodrich R, Escolar G. Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function. Transfusion 2011;51:808-15.
39. Marschner S, Fast LD, Baldwin WM III, Slichter SJ, Goodrich RP. White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion 2010;50:2489-2490.
40. Fast LD, Nevola M, Tavares J, Reddy HL, Goodrich RP, Marschner S. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion 2013. doi: 10.1111/j.1537-2995.2012. 03715.x.
41. Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich RP, Leiby DA. Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion 2012;52:409-16.
42. Thiele T, Sablewski A, Iuga C, Bakchoul T, Bente A, Gorg S, Volker U, Greinacher A, Steil L. Profiling alterations in platelets induced by amotosalen/UVA pathogen reduction and gamma irradiation-a LC-ESI-MS/MS-based proteomics approach. Blood Transfus 2012;10(Suppl. 2):s63-70.
43. Steinmann E, Gravemann U, Friesland M, Doerrbecker J, Muller TH, Pietschmann T, Seltsam A. Two pathogen reduction technologies-methylene blue plus light and shortwave ultraviolet light-effectively inactivate hepatitis C virus in blood products. Transfusion 2013. doi: 10.1111/ j.1537-2995.2012.03858. x.
44. Seltsam A, Muller TH. UVC irradiation for pathogen reduction of platelet concentrates and plasma. Transfus Med Hemother 2011;38:43-54.
45. Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. II. The effects of age, sex and blood group. Br J Haematol 1964;10:238-45.
46. O'Donnell J, Boulton FE, Manning RA, Laffan MA. Amount of H antigen expressed on circulating vonWillebrand factor is modified by ABO blood group genotype and is a major determinant of plasma vonWillebrand factor antigen levels. Arterioscler Thromb Vasc Biol 2002;22:335-337.
47. Goodrich RP, Li J, Pieters H, Crookes R, Roodt J, Heyns Adu P. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang 2006;90:279-85.
48. Babic AM, Josefsson EC, Bergmeier W, Wagner DD, Kaufman RM, Silberstein LE, Stossel TP, Hartwig JH, Hoffmeister KM. In vitro function and phagocytosis of galactosylated platelet concentrates after long-term refrigeration. Transfusion 2007;47:442-51.
49. Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sorensen AL, Larson G, Marth JD, Hartwig JH, Hoffmeister KM. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med 2009;15:1273-80.
50. Rumjantseva V, Hoffmeister KM. Novel and unexpected clearance mechanisms for cold platelets. Transfus Apher Sci 2010;42:63-70.
51. Sorensen AL, Hoffmeister KM, Wandall HH. Glycans and glycosylation of platelets: current concepts and implications for transfusion. Curr Opin Hematol 2008;15:606-11.